Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 101

  • Showing results for myocarditis AND treatment AND immunosuppression AND heart failure. Your search for Myocarditis AND tratment AND immunosupression AND heart failure retrieved no results.
1.

Acute and Fulminant Myocarditis: a Pragmatic Clinical Approach to Diagnosis and Treatment.

Ammirati E, Veronese G, Cipriani M, Moroni F, Garascia A, Brambatti M, Adler ED, Frigerio M.

Curr Cardiol Rep. 2018 Sep 26;20(11):114. doi: 10.1007/s11886-018-1054-z. Review.

PMID:
30259175
2.

Regulatory Role of CD4+ T Cells in Myocarditis.

Vdovenko D, Eriksson U.

J Immunol Res. 2018 Jun 21;2018:4396351. doi: 10.1155/2018/4396351. eCollection 2018. Review.

3.

Immunomodulatory treatment for lymphocytic myocarditis-a systematic review and meta-analysis.

Winter MP, Sulzgruber P, Koller L, Bartko P, Goliasch G, Niessner A.

Heart Fail Rev. 2018 Jul;23(4):573-581. doi: 10.1007/s10741-018-9709-9. Review.

4.

Therapeutic implications of a combined diagnostic workup including endomyocardial biopsy in an all-comer population of patients with heart failure: a retrospective analysis.

Sotiriou E, Heiner S, Jansen T, Brandt M, Schmidt KH, Kreitner KF, Emrich T, Schultheiss HP, Schulz E, Münzel T, Wenzel P.

ESC Heart Fail. 2018 Aug;5(4):630-641. doi: 10.1002/ehf2.12296. Epub 2018 May 10.

6.

Smoldering myocarditis following immune checkpoint blockade.

Norwood TG, Westbrook BC, Johnson DB, Litovsky SH, Terry NL, McKee SB, Gertler AS, Moslehi JJ, Conry RM.

J Immunother Cancer. 2017 Nov 21;5(1):91. doi: 10.1186/s40425-017-0296-4.

7.

Inflammatory Cardiomyopathic Syndromes.

Trachtenberg BH, Hare JM.

Circ Res. 2017 Sep 15;121(7):803-818. doi: 10.1161/CIRCRESAHA.117.310221. Review.

PMID:
28912184
8.

Autoimmune myocarditis in systemic sclerosis: an unusual form of scleroderma heart disease presentation.

Ramalho AR, Costa S, Silva F, Donato P, Franco F, Pêgo GM.

ESC Heart Fail. 2017 Aug;4(3):365-370. doi: 10.1002/ehf2.12139. Epub 2017 Apr 22.

9.

Cerebral tuberculosis in a patient with systemic lupus erythematosus following cyclophosphamide treatment: a case report.

Cooray S, Zhang H, Breen R, Carr-White G, Howard R, Cuadrado M, D'Cruz D, Sanna G.

Lupus. 2018 Apr;27(4):670-675. doi: 10.1177/0961203317722849. Epub 2017 Aug 1.

PMID:
28764615
10.

Myocardial expression of Toll-like receptor 4 predicts the response to immunosuppressive therapy in patients with virus-negative chronic inflammatory cardiomyopathy.

Chimenti C, Verardo R, Scopelliti F, Grande C, Petrosillo N, Piselli P, De Paulis R, Frustaci A.

Eur J Heart Fail. 2017 Jul;19(7):915-925. doi: 10.1002/ejhf.796. Epub 2017 Mar 31.

11.

[Myocarditis].

Hékimian G, Combes A.

Rev Med Interne. 2017 Aug;38(8):531-538. doi: 10.1016/j.revmed.2016.12.022. Epub 2017 Feb 2. Review. French.

PMID:
28161113
12.

Treatment of Acute Necrotizing Eosinophilic Myocarditis With Immunosuppression and Mechanical Circulatory Support.

Howell E, Paivanas N, Stern J, Vidula H.

Circ Heart Fail. 2016 Dec;9(12). pii: e003665. No abstract available.

PMID:
27940496
13.

Emerging pharmacologic targets and treatments for myocarditis.

Jensen LD, Marchant DJ.

Pharmacol Ther. 2016 May;161:40-51. doi: 10.1016/j.pharmthera.2016.03.006. Epub 2016 Mar 20. Review.

PMID:
27009690
14.

Pediatric Cardiac Intensive Care Society 2014 Consensus Statement: Pharmacotherapies in Cardiac Critical Care Immune Therapy.

Singh RK, Humlicek T, Jeewa A, Fester K.

Pediatr Crit Care Med. 2016 Mar;17(3 Suppl 1):S69-76. doi: 10.1097/PCC.0000000000000626. Review.

PMID:
26945331
15.

Fulminant heart failure due to giant cell myocarditis affecting the left ventricle.

Senderek T, Małecka B, Ząbek A, Rudnicka-Sosin L, Wierzbicki K, Przybyłowski P, Bednarek J, Lelakowski J.

Postepy Kardiol Interwencyjnej. 2015;11(4):351-3. doi: 10.5114/pwki.2015.55613. Epub 2015 Jan 12.

16.

Regulatory T cells in cardiovascular diseases.

Meng X, Yang J, Dong M, Zhang K, Tu E, Gao Q, Chen W, Zhang C, Zhang Y.

Nat Rev Cardiol. 2016 Mar;13(3):167-79. doi: 10.1038/nrcardio.2015.169. Epub 2015 Nov 3. Review.

PMID:
26525543
17.

Usefulness of Rabbit Anti-thymocyte Globulin in Patients With Giant Cell Myocarditis.

Suarez-Barrientos A, Wong J, Bell A, Lyster H, Karagiannis G, Banner NR.

Am J Cardiol. 2015 Aug 1;116(3):447-51. doi: 10.1016/j.amjcard.2015.04.040. Epub 2015 May 8.

PMID:
26048854
18.

Long-term risk of recurrence, morbidity and mortality in giant cell myocarditis.

Maleszewski JJ, Orellana VM, Hodge DO, Kuhl U, Schultheiss HP, Cooper LT.

Am J Cardiol. 2015 Jun 15;115(12):1733-8. doi: 10.1016/j.amjcard.2015.03.023. Epub 2015 Mar 24.

PMID:
25882774
19.

Modern day management of giant cell myocarditis.

Chaudhry MA, Correa A, Lee C, Yoon A, Grazette L, Saremi F, Fong MW.

Int J Cardiol. 2015 Jan 15;178:82-4. doi: 10.1016/j.ijcard.2014.10.131. Epub 2014 Oct 23. Review. No abstract available.

PMID:
25464225
20.

Immunosuppressive therapy in myocarditis.

Frustaci A, Chimenti C.

Circ J. 2015;79(1):4-7. doi: 10.1253/circj.CJ-14-1192. Epub 2014 Dec 2. Review.

Supplemental Content

Loading ...
Support Center